Please login to the form below
Capitalising on new drug opportunities in mid-income countries
Opportunities for new drugs in
mid-income countries have come under the spotlight, following a survey by
Charles River Associates (CRA), which says that more could be done to increase
the ‘significant value’ that they are already delivering in five key therapy areas – namely coronary heart
disease (CHD), depression, diabetes, HIV/AIDS and rotavirus infection.
Read the Full article here:
http://www.pmlive.com/digital_handbook/online_audiences/online_physician_communities/capitalising_on_new_drug_opportunities_in_mid-income_countries/
Read the Full article here:
http://www.pmlive.com/digital_handbook/online_audiences/online_physician_communities/capitalising_on_new_drug_opportunities_in_mid-income_countries/
